|
During the 1902 annual meeting of the American Pharmaceutical Association, Harvey Wiley, the Chief Chemist of the Bureau of Chemistry, announced the formation of a Drug Laboratory within his organization. Wiley intended the Laboratory to assist with standardizing pharmaceuticals and unifying analytical results. |
One of the nominees to lead this function was Lyman Frederic Kebler, the Chief Chemist at Smith Kline and French and a
recognized expert in the detection of drug adulteration. Appointed Director of the Drug
Laboratory in November 1902, he assumed the duties in March 1903.
|